We investigated the effects of -and -adrenergic agonists on L-ascorbic acid-induced hepatocyte DNA synthesis and proliferation in primary cultures of adult rat hepatocytes. In addition, possible signal transduction mechanisms for the effects of -and -adrenergic agonists of L-ascorbic acid-induced hepatocyte mitogenesis were examined. The results showed that phenylephrine (10 -6 M) and metaproterenol (10 3
Introduction
L-ascorbic acid, also known as vitamin C, is a nutritional supplement essential for preventing scurvy. L-ascorbic acid is reversibly oxidized in the body to dehydroascorbic acid, which retains full vitamin C activity. Vitamin C is an essential nutrient for the biosynthesis of collagen and L-carnitine, and for the conversion of dopamine to noradrenaline (Tajima and Pinnell, 1982; Li and Schellhorn, 2007) . The liver is an important target for the antioxidant effects of vitamin C, and plays a role in body vitamin homeostasis. L-ascorbic acid and its derivatives can inhibit or stimulate the growth of normal and tumor cells, depending on cell type (Alcain and Buron, 1994; Belin et al., 2009; Koh et al., 1998; Ramírez-Farías et al., 2008; Yang et al., 2006) . However, the cellular mechanisms of these actions are poorly understood.
The response of adult rat hepatocytes to L-ascorbic acid has not been investigated with respect to DNA synthesis and proliferation in vitro. More recently, we reported that L-ascorbic acid and its analogs are able to stimulate hepatocyte DNA synthesis and proliferation during short-term (e.g., 4 h) culture in primary cultures of adult rat hepatocytes by interacting with the insulin-like growth factor (IGF)-I receptor site and by activating the receptor tyrosine kinase/ extracellular-signal regulated kinase (ERK) pathway (Moteki et al., 2012) . ERK1/2, also known as mitogen-activated protein kinase (p42/44 MAPK), is now known to be activated in response to a large number of mitogenic stimuli, and this enzyme is a key participant in the response to various growth factors and cytokines (Ginès et al., 1995; Moriuchi et al., 2001) . In a previous receptor-mediated pathways in regulating hepatocyte proliferation is also discussed.
Materials and Methods

Animals
Male Wistar rats (weight, 200-220 g) were obtained from Saitama Experimental Animal Co. (Saitama, Japan). Rats were adapted to a light-, humidity-and temperature-controlled room over a minimum 3-day period prior to the start of experiments. Rats were fed a standard diet and given tap water ad libitum. Animals used in this study were handled in accordance with the "Guiding Principles for the Care and Use of Laboratory Animals", as approved by the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Guidelines for the Care and Use of Laboratory Animals of Josai University.
Hepatocyte isolation and culture
The methods of hepatocyte isolation and culture were as described elsewhere (Kimura and Ogihara, 1997b) . Briefly, rats were anesthetized with an intraperitoneal injection of sodium pentobarbital (45 mg/kg). Two-step in situ collagenase perfusion was performed to facilitate disaggregation of the adult rat liver, as described previously (Seglen, 1975) . The viability of hepatocytes consistently exceeded 96%, as determined by trypan blue exclusion assay. Unless otherwise indicated, isolated hepatocytes were plated onto 6-well collagen-coated plastic culture dishes (35 mm diameter; Iwaki Glass Co., Tokyo, Japan) at a density of 3.3  10 4 cells/cm 2 in minimum essential medium containing 5% bovine calf serum and 10 -10 M dexamethasone for 3 h in 5% CO 2 in air (Kimura et al., 2011) . The medium was then changed, and cells were cultured in serum-free minimum essential medium containing various concentrations of L-ascorbic acid with or without adrenergic agonists or specific inhibitors of signal transducers. In this study, minimum essential medium was used in place of Williams' medium E because it does not contain L-ascorbic acid, vitamin E or vitamin K. L-ascorbic acid was buffered at pH 7.0 with sodium hydroxide and prepared fresh before each experiment.
Measurement of DNA synthesis
Hepatocyte DNA synthesis was assessed by measuring [ 3 H]-thymidine incorporation into acid-precipitable materials (Morley and Kingdon, 1972) . After an initial attachment period of 3 h, hepatocytes were washed twice with serum-free minimum
Counting number of nuclei
The number of nuclei rather than the number of cells was counted, as described previously, but with minor modifications (Nakamura et al., 1983) . Briefly, primary cultured hepatocytes were washed twice with 2 ml of Dulbecco's phosphate-buffered saline (pH 7.4). Cells were then lysed by incubation in 0.25 ml of 0.1 M citric acid containing 0.1 % Triton X-100 for 30 min at 37C. An equal volume of the nuclear suspension was mixed with 0.3% trypan blue in Dulbecco's phosphate-buffered saline (pH 7.4), and nuclei were counted in a hemocytometer.
Determination of IGF-I receptor tyrosine kinase phosphorylation
Tyrosine phosphorylation of the IGF-I receptor was identified by Western blotting using anti-phosphotyrosine antibody (Li et al., 1994) . The phospho-IGF-I receptor antibody detects IGF-I receptor only when tyrosine 1161 in the carboxyl-terminal region is phosphorylated. This antibody does not cross-react with other tyrosine phosphorylated proteins. Briefly, hepatocytes were freshly isolated and seeded at a density of 3.3  10 4 cells/cm 2 and cultured in minimal essential medium containing 5% newborn bovine serum. The medium was then aspirated and replaced, and cells were further cultured in serum-free minimal essential medium with or without L-ascorbic acid for various lengths of time. Cultured hepatocytes were washed once with ice-cold phosphate-buffered saline (pH 7.4) and then 0.2 ml of lysis buffer (20 mM Tris buffer, pH 7.5, 1% Triton X-100, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 2.5 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 1 mM -glycerophosphate and 1 mM phenylmethylsulfonyl fluoride) was added. Cell lysates were obtained by scraping the cells in lysis buffer, followed by sonication for 3 min. Cell lysates were centrifuged (3000  g for 3 min at 4C) to remove cellular debris, and were then denatured in boiling water for 5 min. For immunoblotting analysis, samples of the supernatant (30 g/lane) were resolved by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) using a 7.5% polyacrylamide resolving gel, transferred to a polyvinylidene difluoride (PVDF) membrane, and immunoblotted with anti-phosphotyrosine antibody (Li et al., 1994) . Blots were developed by enhanced chemiluminescence following incubation with horseradish peroxidase (HRP)-conjugated secondary antibodies. The tyrosine kinase activity (autophosphorylation) of the phosphorylated p95-kDa protein (P-p95-kDa) was normalized against that of total p95-kDa protein. Quantification was performed by densitometry after development of the membrane with enhanced chemiluminescence reagent and exposure to Hyperfilm (Kodak, Japan). Densitometric analysis was performed using the NIH image program version 1.6 for Macintosh. Data were calculated in arbitrary units and are expressed as means ± S.E.M. The autodiagram is representative of three experiments using different cell preparations.
Measurement of extracellular signal-regulated kinases 1 and 2 (ERK1/2) phosphorylation
Phosphorylated ERK isoforms (pERK1; P-p44 MAPK and pERK2; P-p42 MAPK)
were identified by Western blotting analysis using anti-phospho-ERK1/2 monoclonal antibody, as previously described (Towbin et al., 1979) . Phosphorylated ERK1/2 phosphorylation was normalized against total ERK1/2 levels. Briefly, cultured hepatocytes were washed once with ice-cold phosphate-buffered saline (pH 7.4) and 0.2 ml of lysis buffer (10 mM Tris-HCl buffer (pH 7.4), 150 mM NaCl, 2 mM EGTA, 2 mM dithiothreitol, 1 mM sodium orthovanadate, 1 mM phenylmethylsulphonyl fluoride, 10 g/ml leupeptin and 10 g/ml aprotinin) was added, after which hepatocytes were harvested. After centrifugation at 16,300 × g for 30 min at 4C, cell lysates were denatured in boiling water for 5 min. Supernatant samples (30 g of protein) were subjected to SDS-PAGE using a 10% acrylamide resolving gel according to the method of Laemmli (Laemmli, 1970) . After electrophoresis, proteins were transferred to Immobilon-P membranes.
For detection of phosphorylated extracellular-regulated kinase 1 and 2 (pERK1/2), membranes were immersed in Tris-buffered saline (pH 7.4) containing 1% bovine serum albumin. Membranes were then incubated with an antibody (1 g/ml) against pERK1/2 and/or ERK1/2, and were washed as described previously (Towbin et al., 1979) . Antibody binding was visualized by incubation with a horseradish peroxidase-conjugated donkey anti-rabbit IgG secondary antibody (1:3000 dilution), followed by enhanced chemiluminescence detection (ECL Kit; Amersham, UK).
Densitometric analysis was performed using NIH Image version 1.68 for Macintosh.
Data were calculated in arbitrary units and are expressed as means ± S.E.M.
Cytosolic protein in hepatocytes was quantified by modification of the Lowry procedure using bovine serum albumin as a standard (Lee and Paxman, 1972) .
Materials
The following reagents were obtained from Sigma-Aldrich (St. Louis, MO): AG538
aprotinin, 2,4-dideoxyadenosine, and dexamethasone. Rapamycin and PD98059
(2'-amino-3'-methoxyflavone) were obtained from R & D Systems (Minneapolis, MN).
hydrochloride, phenylephrine hydrochloride, UK14304
(5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine), and U-73122 thymidine (20 Ci/mmol) was purchased from DuPont-New England Nuclear (Boston, MA). All other reagents were of analytical grade.
Statistical Analysis
Group comparisons were made by ANOVA for unpaired data followed by post-hoc analysis using Dunnett's multiple comparison tests. Differences of P<0.05 were considered to be statistically significant. Smith et al., 1983) alone had no effect on hepatocyte DNA synthesis and proliferation. However, when combined, both phenylephrine and metaproterenol stimulated hepatocyte DNA synthesis (10.0-fold increase from baseline) and proliferation (1.4-fold increase from baseline) induced by L-ascorbic acid (10 -6 M).
Results
Potentiation of hepatocyte
The cell-permeable cAMP analog 8-bromo cAMP, a direct PKA activator (Derubertis and Zenser, 1976) , and the direct PKC activator TPA also potentiated the L-ascorbic acid-induced hepatocyte DNA synthesis and proliferation. The  2 -adrenegic receptor agonist UK14304 (Remaury et al., 1993 ) had no effect on the L-ascorbic acid-induced hepatocyte mitogenesis. However, the enhancing effects of metaproterenol on hepatocyte DNA synthesis and proliferation in the presence of L-ascorbic acid were inhibited by UK14304.
In order to confirm the notion that 10 -6 M L-ascorbic acid induces hepatocyte DNA synthesis and proliferation through receptor tyrosine kinase, PI3 kinase, ERK or the mammalian target of rapamycin (mTOR) phosphorylation, we investigated whether the IGF-I receptor tyrosine kinase inhibitor AG538 (Blum et al., 2000) , the PI3 kinase inhibitor LY294002 (Vlahos et al., 1994) , the MEK inhibitor PD98059 (Alessi et al., 1995) and the mTOR inhibitor rapamycin (Chung et al., 1992; Price et al., 1992) are able to inhibit L-ascorbic acid-induced hepatocyte DNA synthesis and proliferation in the presence or absence of metaproterenol and phenylephrine. Specific inhibitors of growth-related signal transducers, such as AG538 (10 -7 M), LY294002 (10 -7 M), PD98059 (10 -6 M) and rapamycin (10 ng/ml) almost completely blocked L-ascorbic acid-induced hepatocyte DNA synthesis and proliferation in the presence or absence of phenylephrine (10 -6 M) and metaproterenol (10 -6 M).
Effects of metaproterenol, 8-bromo cAMP, phenylephrine and TPA on L-ascorbic acid-induced IGF-I receptor tyrosine kinase phosphorylation
In order to obtain further evidence for the cross-talk between the IGF-I receptor mediated-tyrosine kinase/ERK1/2 kinase pathway (ERK1/2 phosphorylation) and the  1 -,  2 -and  2 -adrenergic receptor-mediated pathway, we examined the effects of  1 -,  2 -and  2 -adrenergic receptor agonists on IGF-I receptor tyrosine kinase (Tyr1161) phosphorylation ( specifically potentiated L-ascorbic acid-induced ERK2 phosphorylation.
Effects of specific inhibitors of signal transducers on metaproterenol or 8-bromo cAMP-induced ERK1/2 isoform phosphorylation in presence of L-ascorbic acid
In order to investigate the mechanisms by which the  2 -adrenergic receptor/protein 
Time course and pattern of L-ascorbic acid stimulation of ERK isoform phosphorylation, and their potentiation by  1 -adrenergic agonist phenylephrine
The effects of an  1 -adrenergic agonist on the induction of ERK phosphorylation by 10 -6 M L-ascorbic acid were investigated using phenylephrine. L-ascorbic acid in the presence of phenylephrine (10 -6 M; an indirect PKC activator) caused a more rapid and significant increase in ERK2 phosphorylation than L-ascorbic acid alone. ERK2 phosphorylation peaked at 3 min (about 3.0-fold increase from baseline) after addition and rapidly decreased to basal levels within 30 min (Figs. 6A and 6B). In contrast, phenylephrine alone did not significantly stimulate ERK2 phosphorylation (data not shown). Phenylephrine (10 -6 M) in the presence of 10 -6 M L-ascorbic acid did not significantly stimulate ERK1 phosphorylation (Fig. 6C ). The present findings indicate that phenylephrine potentiates L-ascorbic acid-induced ERK2 phosphorylation.
Effects of specific inhibitors of signal transducers on phenylephrine-or
TPA-Induced ERK isoform phosphorylation in presence of L-ascorbic acid
The effects of an  1 -adrenergic agonist on induction of ERK1/2 phosphorylation by 10 -6 M L-ascorbic acid were investigated using phenylephrine (10 -6 M) and a direct PKC activator TPA (10 -7 M). When hepatocytes were stimulated with L-ascorbic acid in the presence of phenylephrine (10 -6 M), or TPA (10 -7 M), significant potentiation of ERK2 phosphorylation was also observed when compared with L-ascorbic acid (10 Phenylephrine (10 -6 M), TPA (10 -7 M), U-73122 (10 -6 M) or GF109203X alone had no significant effects on the phosphorylation of ERK1 or ERK2 (Fig. 7) .
Discussion
As shown in Figs. 1A and 1B, we found that both the  1 -adrenergic agonist phenylephrine and the  2 -adrenergic agonist metaproterenol potentiated the hepatocyte DNA synthesis and proliferation induced by L-ascorbic acid (10 -6 M). The potentiating effects of phenylephrine and metaproterenol on the L-ascorbic acid-induced hepatocyte DNA synthesis and proliferation were almost completely blocked by inhibitors of growth-related signal transducers, such as AG538 (10 -7 M), LY294002 (10 -7 M), PD98059 (10 -6 M) and rapamycin(10 ng/mL) (Fig. 1) . These results suggest that there is cross-talk between  1 -and  2 -adreneric receptor-mediated pathway and IGF-I receptor-mediated pathway in the regulation of L-ascorbic acid-induced hepatocyte mitogenesis. In addition, the enhancing effects of  2 -adrenergic receptor agonist metaproterenol on hepatocyte DNA synthesis and proliferation in the presence of L-ascorbic acid were inhibited by  2 -adrenergic receptor agonists UK14304 (Fig.1) .
In order to obtain further evidence for the cross-talk between L-ascorbic acid-induced IGF-I receptor tyrosine kinase/ERK1/2 kinase activation (ERK1/2 phosphorylation) and  1 -or  2 -adrenergic receptor activation, we examined the effects of specific inhibitors or activators of growth-related signal transducers and  2 -and hepatocytes. Therefore, we examined whether  2 -and  2 -adrenergic agonists modulate the L-ascorbic acid-induced changes in ERK2 phosphorylation.
As shown in Fig. 3 , we found that L-ascorbic acid-induced hepatocyte ERK2 phosphorylation was enhanced by metaproterenol (10 -6 M), an indirect adenylate cyclase (AC) activator, after 5 min of culture (Figs. 3 and 4) . In contrast, metaproterenol alone had no significant effects on hepatocyte ERK1/2 phosphorylation in the absence of L-ascorbic acid (Fig. 4) . As shown in a recent report, L-ascorbic acid (10 -6 M) at a concentration that induces hepatocyte DNA synthesis and proliferation rapidly stimulated ERK2, but not ERK1 phosphorylation (Moteki et al., 2012) . Fremin et al. showed that continued expression of cyclin-D1 in the G 0 /G 1 phase is dependent on ERK2 expression by L-ascorbic acid, and that the ablation of ERK1 influences neither the proliferation capacity of mice hepatocytes in this regulation, in vivo and in vitro, nor the expression pattern of cyclin-D1 (Frémin et al., 2007) . In agreement with a recent report, our data indicate that ERK2 plays a key role in hepatocyte proliferation (Frémin et al., 2007; Frémin et al., 2012) . Moreover, L-ascorbic acid induction of The enhancing effects of metaproterenol in the presence of L-ascorbic acid were inhibited by  2 -adrenegic receptor agonist UK14304 (10 -6 M; indirect AC inhibitor which decreases cAMP), 2,4-dideoxyadenosine (10 -6 M; direct AC inhibitor) and the PKA inhibitor H-89, thus suggesting the involvement of PKA in the potentiating effects of metaproterenol (Fig. 4) . The involvement of PKA in the effects of metaproterenol is supported by our previous results, which indicated that metaproterenol-induced potentiation of hepatocyte DNA synthesis and proliferation in the presence of L-ascorbic acid (10 -6 M) was completely inhibited by a specific PKA inhibitor, H-89 (data not shown).
However, the role of the second messenger cAMP in the control of hepatocyte DNA synthesis and proliferation remains uncertain (Brønstad et al., 1983; Liu et al., 2005) . cAMP can either stimulate or inhibit DNA synthesis, depending on culture conditions (Kimura and Ogihara, 1998; Brønstad et al., 1983; Liu et al., 2005) . We demonstrated that the cell-permeable cAMP analog 8-bromo cAMP dose-dependently enhances We examined whether an  1 -adrenergic agonist modulates the L-ascorbic acid-induced changes in ERK2 phosphorylation. As shown in Figs. 6 and 7, while an  1 -adrenergic agonist phenylephrine alone had no effect on hepatocyte ERK phosphorylation in the absence of L-ascorbic acid, L-ascorbic acid-induced ERK2 phosphorylation was enhanced by phenylephrine. The enhancing effects of phenylephrine in the presence of L-ascorbic acid was inhibited by the PKC inhibitor, GF109203X (10 -7 M), thus suggesting the involvement of PKC in the potentiating effects of phenylephrine (Fig. 7) . The involvement of PKC in the phenylephrine effect is supported by our previous results, indicating that phenylephrine-induced potentiation of hepatocyte DNA synthesis and proliferation in the presence of L-ascorbic acid (10 -6 M) was completely inhibited by a specific PKC inhibitor, GF109203X (data not shown).
However, the roles of second messengers, such as IP 3 and diacylglycerol, in the control of hepatocyte DNA synthesis and proliferation remain uncertain (Berridge, 1993) . Phorbol ester, 12-O-tetradecanoylphorbol-13-acetate (TPA; 10 -7 M), a direct activator of PKC, can either directly or indirectly stimulate DNA synthesis depending on culture conditions (Kimura and Ogihara, 1998; Ginès et al., 1995; O'Brien et al., 1979) . In addition,  1 -adrenergic receptor-mediated signals may interact with upstream signal transducers, such as the MEK, raf or ras pathways (Ramirez et al., 1997; Xiao et al., 2001) , and have a positive influence normal liver growth and liver regeneration after partial hepatectomy in vivo (Huh et al., 2004; Beyer et al., 2008) . As shown in Fig.7 , both phenylephrine (indirect PLC/PKC activator)-and TPA-induced potentiation of ERK2 phosphorylation in the presence of L-ascorbic acid were completely inhibited by AG538, LY294002 and PD98059, but not by rapamycin (Fig. 7) . Thus, the  1 -adrenergic receptor/ PLC/ PKC pathway may interact with upstream elements such as raf or ras (Ginès et al., 1995; Ramirez et al., 1997; Xiao et al., 2001 ).
Based on the present data, a possible scheme for cross-talk between the L-ascorbic acid-targeted IGF-I receptor/ERK2 pathway and the  1 -adrenergic receptor/PLC/PKC pathway and/or  2 -adrenergic receptor/AC/PKA pathway is summarized in Fig. 8 . The cross-talk signals of the  1 -and  2 -adrenergic pathway may influence growth-related signal transducers such as Ras, Raf and MEK that lie downstream of the IGF-I receptor tyrosine kinase, but upstream of ERK (Ginès et al., 1995; Ramirez et al., 1997; Xiao et al., 2001; Pollak et al., 2004) . More detailed mechanisms of cross-talk between the L-ascorbic acid-signaling pathway and the  1 -receptor/PLC/PKC and/or  2 -adrenergic receptor/AC/PKA pathway remain to be explored.
In conclusion, the present study demonstrates that the cross-talk signals by extracellular (10 -7 M), LY294002 (10 -7 M), PD98059 (10 -6 M), rapamycin (10 ng/ml), H-89 (10 -7 M) or 2,4,-dideoxyadenosine (10 -6 M) and/or  2 -adrenegic receptor agonist UK14304
(10 -7 ,10 -6 M). Phosphorylated ERK isoforms (pERK1 and pERK2) were determined by
Western blotting using an anti-phospho-ERK1/2 antibody, as described in the legend to 
